BofA lowered the firm’s price target on ArcBest (ARCB) to $72 from $73 and keeps a Neutral rating on the shares after the company posted in-line November results in its mid-Q4 update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARCB:
- ArcBest’s Mixed Performance and Neutral Rating Amid Market Challenges
- ArcBest price target lowered to $83 from $87 at Citi
- ArcBest Reports November 2025 Financial Performance Update
- ArcBest Amends Credit Facility for Increased Flexibility
- ArcBest’s Promising Growth Trajectory: A Buy Recommendation Amid Market Skepticism